Fractyl Health(GUTS) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates Randomized 3-month REMAIN-1 Midpoint Cohort data expected in September 2025 Positive 3-month REVEAL-1 Cohort data showed single Revita ® procedure sustained weight loss after GLP-1 discontinuation; incremental 6-month open-label data expected in Q4 2025 Top-line REMAIN-1 Pivotal Cohort 6-month data and PMA filing expected in H2 2026 Recent Highlights and Upcoming Milestones Revita ® The Company is evaluating Rev ...